income

The new label will note that the product is capable of killing hepatitis B, hepatitis C and multiple Carbapenem-resistant bacteria. The label also mentions that it can kill viruses as quickly as 30 seconds after application.

Pure Bioscience has a potential upside of 49.6% based on a current price of $1.17 and an average consensus analyst price target of $1.75.

After it announced that the U.S. Environmental Protection Agency has approved an expanded label for its low-toxic disinfectant PURE Hard Surface, shares of chemicals-developer Pure Bioscience (NASDAQ:PURE) jumped 17% to $1.15.

He Li, Vice President of Air China said "The introduction of this brand new aircraft is not only a milestone in the cooperation history between Boeing and Air China, but also an important symbol to deepen our relationship. The 777

This week, Boeing (NYSE:BA) delivered its first 777-300ER (extended range) to Air China. The new airplane is the first of 19 777-300 ERs Air China ordered with Boeing.

Goodrich raised it's full-year earnings outlook to a range of $5.55 to $5.85 a share, against its prior outlook of $5.40 to $5.55 a share.

Analysts surveyed by FactSet Research were looking for 2011 earnings of $5.62 a share.

Goodrich has a potential upside of 6.5% based on a current price of $98.14 and an average consensus analyst price target of $104.5.

After modifying its full year outlook to reflect the growing demand for its aircraft maintenance services, Goodrich Corp.'s (NYSE:GR) shares rose over 5%.

The bank's business condition index rose from negative 7.7 in June to 3.3 in July, surprising analysts. Economists expected the index to move up to negative 2.7.

The index for new orders rose from negative 7.6 in June to 0.1 in July.

The index for number of employees increased from 4.1 in June to 8.9 in July.

The Philadelphia Federal Reserve reported that the Philadelphia region's manufacturing activity has rebounded.

James P. Gorman, President and Chief Executive Officer, said, "While global markets remained challenging this quarter, the Firm delivered higher year-over-year revenues across our three major business segments. Within Institutiona

Morgan Stanley (NYSE:MS) reported Q2 loss of $0.32 a share versus the analyst estimate loss of $0.62. Revenue for the quarter rose, 16.6% to $9.3 billion better than consensus estimate of $8.04 billion.

Jay Fishman, Chairman and Chief Executive Officer commented, "Our second quarter loss was due to the extraordinary tornadoes and hail storms that caused devastation across significant portions of the United States.

Travelers (NYSE:TRV) reported a Q2 loss of $0.91 per share, wider than consensus estimates for a loss of $0.61 per share. Revenues rose 3.1% year-over-year to $5.50 billion, missing consensus estimates of $5.52 billion.

Kevin T. Kabat, president and CEO of Fifth Third Bancorp said, "Fifth Third's second quarter results were strong and reflected continued improvement in credit trends.

Fifth Third Bancorp (NASDAQ:FITB) reported Q2 EPS of $0.35, ahead of consensus estimates of $0.27 per share. Net charge-offs for the quarter were $304 million. Total nonperforming assets of $2.3 billion fell $78 million sequential

Equity futures are pointing higher this morning with the Dow Jones Industrial Average looking to open 72 points higher while the broader S&P500 index is looking to open over 8 points higher.

Scott D. Farmer, Chief Executive Officer, stated, "Our fourth quarter organic growth rate of 8.0% represents the fifth straight quarter that our organic growth rate improved.

Cintas Corporation (NASDAQ:CTAS) reported 2011 fourth quarter EPS today of $0.49 better than analyst estimates of $0.43. Revenues in the quarter rose, 11.3% year-over-year to $1.01 billion better than consensus estimates of $967.4

Mark Peek, chief financial officer of the company commented on the report, "VMware's second quarter results were driven by strength across geographies and record enterprise license agreement bookings as a percentage of total booki

VMware (NYSE:VMW) reported second quarter EPS of $0.55, ex-items, topping consensus estimates of $0.47 per share. Revenues for the quarter were $921 million, ahead of consensus estimates of $872 million.